Anne-Mieke Vandamme
Anne-Mieke Vandamme
Full professor, KU Leuven, Belgium
Bestätigte E-Mail-Adresse bei uzleuven.be - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
9672009
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
K Verdonck, E González, S Van Dooren, AM Vandamme, G Vanham, ...
The Lancet infectious diseases 7 (4), 266-281, 2007
6672007
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
5402005
An automated genotyping system for analysis of HIV-1 and other microbial sequences
T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ...
Bioinformatics 21 (19), 3797-3800, 2005
5372005
Tracing the origin and history of the HIV-2 epidemic
P Lemey, OG Pybus, B Wang, NK Saksena, M Salemi, AM Vandamme
Proceedings of the National Academy of Sciences 100 (11), 6588-6592, 2003
5342003
The phylogenetic handbook: a practical approach to phylogenetic analysis and hypothesis testing
P Lemey, M Salemi, AM Vandamme
Cambridge University Press, 2009
4492009
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS Med 2 (4), e112, 2005
3652005
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event
L Vijgen, E Keyaerts, E Moës, I Thoelen, E Wollants, P Lemey, ...
Journal of virology 79 (3), 1595-1604, 2005
3572005
European guidelines on the clinical management of HIV-1 tropism testing
LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ...
The Lancet infectious diseases 11 (5), 394-407, 2011
2882011
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
2832009
Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools
AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ...
Infection, genetics and evolution 19, 337-348, 2013
2482013
2', 5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole-2'', 2'-dioxide) pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human …
J Balzarini, MJ Perez-Perez, A San-Felix, D Schols, CF Perno, ...
Proceedings of the National Academy of Sciences 89 (10), 4392-4396, 1992
2371992
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS Med 12 (4), e1001810, 2015
2312015
Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
R Pauwels, K Andries, Z Debyser, P Van Daele, D Schols, P Stoffels, ...
Proceedings of the National Academy of Sciences 90 (5), 1711-1715, 1993
2231993
phylogenetic handbook
M Salemi, AM Vandamme
Cambridge University Press, 2003
2102003
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A
L Coelmont, X Hanoulle, U Chatterji, C Berger, J Snoeck, M Bobardt, ...
PloS one 5 (10), e13687, 2010
2002010
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase
J Balzarini, A Karlsson, MJ Perez-Perez, L Vrang, J Walbers, H Zhang, ...
Virology 192 (1), 246-253, 1993
1911993
Updated European recommendations for the clinical use of HIV drug resistance testing
AM Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, ...
Antiviral therapy 9 (6), 829-848, 2004
1872004
Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolution
M Salemi, K Strimmer, WW Hall, M Duffy, E Delaporte, S Mboup, ...
The FASEB Journal 15 (2), 276-278, 2001
1852001
A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients
K Van Laethem, A De Luca, A Antinori, A Cingolani, CF Perna, ...
Antiviral therapy 7 (2), 123-9, 2002
1752002
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20